T Cell Activation Triggers Calcium-Dependent Expression of the Aging Marker p16INK4a
Noah Lepola, Xiangnan Guan, Christin Burd

TL;DR
T cell activation increases p16INK4a, an aging marker, through calcium and NFAT signaling, revealing a new mechanism for immune cell aging.
Contribution
Identifies calcium-dependent NFAT signaling as a novel regulatory mechanism for p16INK4a in T cells.
Findings
T cell activation increases p16INK4a mRNA and protein in mouse and human T cells.
CD3 signaling drives p16INK4a induction, enhanced by IL-2 but not CD28.
NFAT/Sp1 binding site in the p16INK4a promoter is required for activation after T cell stimulation.
Abstract
p16INK4a is a senescence-associated cell cycle inhibitor and aging biomarker. Gerontogenic factors, including chemotherapy, smoking, and physical inactivity lead to durable increases in human peripheral blood T cell (PBTL) p16INK4a levels. However, the mechanisms that regulate p16INK4a in T cells remain uncertain. Here, we show that T cell activation signals induce p16INK4a mRNA and protein in mouse and human T cells. This induction is primarily driven by CD3 signaling, and is further enhanced by IL-2, but not by CD28 co-stimulation. Using luciferase reporter assays in Jurkat cells, we identify a predicted NFAT/Sp1 binding site in the p16INK4a promoter that is required for reporter activation following T cell stimulation. Furthermore, cyclosporine A-mediated inhibition of calcium signaling and NFAT activation limits endogenous p16INK4a expression during T cell stimulation. These…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSignaling Pathways in Disease · Cancer-related Molecular Pathways · Histone Deacetylase Inhibitors Research
